ClinicalTrials.govpublic full text
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
kshv inflammatory cytokine syndrome (kics), kaposi sarcoma herpesvirus -associated multicentric castleman disease, jak2, interleukin-1, interleukin 6 receptor, lymphoproliferative disorder, hiv, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 904295
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.